|
|
Volumn 20, Issue 15, 2002, Pages 1909-1911
|
|
HIV vaccine evaluation center in Rio de Janeiro, Brazil
|
|
Author keywords
ELISA assay; HIV seroincidence; Post sexual exposure chemoprophylaxis
|
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
LAMIVUDINE;
MN RGP 120;
SUBUNIT VACCINE;
UNCLASSIFIED DRUG;
VCP1452 VACCINE;
VIRUS VECTOR;
ZIDOVUDINE;
ADULT;
AGE;
ARTICLE;
BRAZIL;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SAFETY;
DRUG SCREENING;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FOLLOW UP;
HETEROSEXUALITY;
HIGH RISK POPULATION;
HOMOSEXUALITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOGENICITY;
INFECTION PREVENTION;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
PHASE 2 CLINICAL TRIAL;
POPULATION;
PRIORITY JOURNAL;
SEROCONVERSION;
SEX DIFFERENCE;
SEXUAL BEHAVIOR;
VIRUS TRANSMISSION;
ADOLESCENT;
ADULT;
AIDS VACCINES;
ANTI-HIV AGENTS;
BEHAVIOR THERAPY;
BISEXUALITY;
BRAZIL;
CLINICAL TRIALS, PHASE II;
DISEASE TRANSMISSION, HORIZONTAL;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FOLLOW-UP STUDIES;
HIV ANTIBODIES;
HIV ENVELOPE PROTEIN GP120;
HIV INFECTIONS;
HIV SEROPOSITIVITY;
HOMOSEXUALITY;
HUMANS;
INCIDENCE;
LAMIVUDINE;
MALE;
MIDDLE AGED;
SAFETY;
SENSITIVITY AND SPECIFICITY;
ZIDOVUDINE;
|
|
EID: 0037029872
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(02)00065-8 Document Type: Article |
|
Times cited : (9)
|
|
References (4)
|
